Explore 3 Stock Ideas & Industry Insights Download Free Report
Atlas Lithium Corporation
Atlas Lithium Corporation (NASDAQ: ATLX) is a lithium-focused development company working toward bringing its Neves Project into production. Its asset base spans roughly 797 square kilometers of lithium-bearing properties, alongside additional exploration holdings in key battery and critical minerals such as nickel, copper, rare earth elements, graphite, and titanium.
As per US Dailies Report published on ‘ATLX’ on Jan 13, 2026, Kalkine provided an ‘Buy’ stance on the stock at USD 5.44 based on fundamental analysis and the stock price has now moved up by ~ 18.93% since then.
Noted below are the details of support and resistance levels provided in our previous report:

Rationale:
Atlas Lithium continues to strengthen its strategic position through the successful Nasdaq listing of its critical minerals subsidiary, rapid progress toward production at the Neves Project, and a solid balance sheet with strong liquidity and minimal leverage. The Company’s extensive mineral portfolio in Brazil adds long-term optionality beyond lithium, while robust contractor interest and advanced procurement signal smooth execution ahead.
Share Price Chart

Conclusion
Given a highly capital-efficient project supported by strong DFS economics, key permits in place, and infrastructure ready for assembly, the stock’s recent momentum appears increasingly supported by tangible operational and financial milestones, a "Sell" recommendation on Atlas Lithium Corporation (NASDAQ: ATLX) has been given at the current market price of USD 6.47 as on 27 January 2026 at 8:27 am PST.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is 27 January 2026. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: Target Price refers to a price level which the stock is expected to reach as per the relative valuation method and/or technical analysis taking into consideration both short-term and long-term scenario.
Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the London Stock Exchange (LSE) and or REFINITIV. Typically, both sources (LSE and or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.’
Note 6: Dividend Yield may vary as per the stock price movement.
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
Past performance is not a reliable indicator of future performance.
Please wait processing your request...
You are not subscribed for this report, Want to See?
One of our sales representative will contact you soon!
Welcome to Kalkine!
Start Your 7-Days Free Trial Today!
Hi! How can we help you today?
Loading…